Delivery Order SPE2DB24D1021-SPE2DB25FFAEY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,298.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on a firm fixed-price basis. The contract, issued on September 4, 2025, with completion targeted for September 25, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $18,245 delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on August 7, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The company, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $5,473.50. This firm fixed price delivery order, with an ultimate completion date of September 12, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $5,473.50 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This competitive, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $10,947.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on July 28, 2025, with completion scheduled for August 18, 2025. This firm fixed-price delivery order, placed under a competitive procurement with no set-aside designation, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Gel-One is a viscosupplementation product used primarily for joint pain management,...
- The Defense Logistics Agency awarded a delivery order valued at $1,459.60 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL) on August 29, 2025, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, non-set-aside delivery order issued without competitive restrictions, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The product will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,947 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 4, 2025, with completion targeted for September 25, 2025. This non-competitive delivery order was issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The product will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 20, 2025, for Gel-One 30 mg/3 mL syringes valued at $10,947.00 through a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 11, 2025, and will be fulfilled from the company's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.50 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitive contract award, which carries no set-aside designation, is structured as a firm fixed price delivery order. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAEYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,459.60. This competitively awarded, firm fixed-price delivery order is classified as a child contract and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The product will be performed at the company's headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. Gel-One is a viscosupplementation product used in orthopedic and rheumatologic applications, reflecting the Defense Logistics Agency's procurement of specialized medical supplies for military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's contract portfolio with the Defense Logistics Agency demonstrates consistent success in meeting federal procurement requirements across multiple therapeutic domains and product categories, positioning the company as a primary vendor for the Military Health System's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/4/25 |